Purchases and Sales Made in Q4 2023 in Gracell Biotechnologies Inc. (GRCL)
This table provides information about the institutional ownership of Gracell Biotechnologies Inc. (GRCL) during Q4 2023. The information is specifically focused on institutions that hold shares of Gracell Biotechnologies Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 12, 2024
Q4 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-2.26K- 3.47% |
$5.5K - $22.7K
|
62.9K
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-7.3K- 15.67% |
$17.7K - $73.3K
|
39.3K
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-19.5K- 3.48% |
$47.3K - $195K
|
540K
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-20.5K- 20.81% |
$49.9K - $206K
|
78.1K
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-29K- 84.13% |
$70.4K - $291K
|
5.47K
$0
|
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-301K- 96.62% |
$731K - $3.02M
|
10.5K
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Temasek Holdings (Private) LTD
Singapore, U0 |
SELL
|
- |
-313K- 3.16% |
$761K - $3.14M
|
9.59M
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-1.03M- 67.16% |
$2.5M - $10.3M
|
503K
$0
|
|
|
Feb 06, 2024
Q4 2023
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-1.33M- 12.27% |
$3.24M - $13.4M
|
9.55M
$0
|
|
|
Feb 14, 2024
Q4 2023
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-1.73M- 86.67% |
$4.21M - $17.4M
|
267K
$0
|